Background: Malnutrition is very common in patients with chronic obstructive pulmonary disease (COPD). Nutritional supplementation improves the patient's nutritional status by increasing the energy intake and providing antiinflammatory elements which can relieve the patient's symptoms and delay the disease progression. This study sought to determine if energy and protein supplementation improves physical function, pulmonary function and healthrelated quality of life (HRQL) in stable COPD patients.
INTRODUCTION
Chronic obstructive pulmonary disease is an important health problem across the globe. The disease is characterized by persistent airflow obstruction which is progressive resulting from inflammation and remodeling of the airways and lungs stimulated by exposure to toxins mainly due to a history of cigarette smoking (1) . It has been recognized as the third leading cause of death and TANAFFOS continues to be the major cause of mortality and morbidity worldwide (2) .
According to the World Health Organization consensus, 4.8% of the world population was diagnosed with COPD in 2010 (3) . In 2005, more than 3 million people died of COPD accounting for 5% of all deaths globally and it is expected to become the third leading cause of death by 2030 (4) . The current prevalence of COPD is not uniformly available in the Indian population. Although studies done by Murthy and Sastri (5) and Jindal (6) . have reported the average prevalence rate of 5% in the adult population, higher rates have been reported in smokers, males, and rural areas.
Malnutrition is very common in patients with COPD.
Insufficient energy intake and systematic inflammation lead to malnutrition in these patients (7) . Common clinical systemic manifestations are changes in body composition, metabolism and immune status which often lead to weight loss, dyspnea, fatigue, reduced exercise tolerance, poorer prognosis, increased susceptibility to infections and impaired quality of life independent of pulmonary function (8) .
Weight loss in COPD may be due to an increased energy expenditure imbalance caused by inadequate dietary intake which leads to reduction of diaphragmatic muscle mass and depressed diaphragm contractility (9) 
Resting energy expenditure (REE), total daily energy needed, systemic inflammation and tissue hypoxia have been reported to be elevated in stable COPD patients and are considered to be a part of pathophysiologic mechanisms for weight loss (10, 11) . Patients with COPD experience gradual and progressive loss of skeletal muscle mass which not only affects their respiratory function but also causes muscle fatigue. This may further lead to reduction in exercise capacity and the ability to work (12) .
Malnourished patients demonstrate more gas trapping, lower diffusing capacity and a reduced exercise performance than non-malnourished patients with similar pulmonary mechanics (13) .
Several attempts have been made to find an association between malnutrition and impaired pulmonary function in patients with COPD (14) (15) (16) . However, the exact causal relationship between malnutrition and COPD is difficult to establish and not clear yet. Malnutrition in COPD may be the consequence of worsened disease severity leading to compromised nutritional intake and reduced physical activity (muscle atrophy) and may alternatively be responsible for the wasting of muscles involved in breathing due to the progressive nature of COPD (17) .
Malnourished COPD patients also have been reported to score worse than non-malnourished patients on a respiratory disease specific quality of life questionnaire (17, 18) . 
MATERIALS AND METHODS

Study Population
This was a prospective interventional study with 60
clinically stable patients of COPD attending chest clinic of our hospital. The study was done at Maulana Azad Medical College and associated Lok Nayak Hospital, New
Delhi over a period of one year. The study had the following inclusion criteria: 
Study design
A single-blind randomized, parallel group, design was used. After baseline assessment, the eligible patients were allotted by computer generated random numbers to one of the two groups and followed up for 12 weeks. A total of 65 patients were screened, out of which 60 patients were recruited and randomized into two groups of intervention and control (n=30 in each group). Those who were dropped out or in whom the investigations could not be completed were excluded leaving 3 and 2 patients, in intervention group and control group respectively. 
RESULTS
Baseline evaluation:
Totally 60 patients were enrolled in the study and were evaluated prospectively with 30 patients in each group.
The clinical and demographic characteristics were comparable (age, height, weight and smoking) in both groups ( Table 1 ). The mean age of the intervention group was 55.03±10.41 yrs. and that of control group was 53.33±10.76 yrs. Fifty-eight patients out of 60 (96%) were smokers in this study. No subject attended a pulmonary rehabilitation program while participating in the study.
Baseline characteristics of the patients are summarized in Tables 1 and 2 . The mean arterial blood gases was normal.
No baseline differences between the intervention and the control group were seen with regards to BMI, arterial oxygen tension, FEV1, 6MWD, HRQL, Serum protein, MUAC, and SFT at baseline ( Table 2) . 
Post intervention evaluation:
There was a significant increase in weight and BMI of the patients in the intervention group but none in control group after 12 weeks of nutritional supplementation. In this study there were 12 patients in the study group and 18 patients in the control group with BMI < 18.5 Kg/m 2 meaning that 30 out of 60 patients were underweight i.e., incidence of malnutrition in this study was 50%.
The difference in the mean changes of studied parameters within and between the groups at the end of 8 weeks is shown in Table 3 . The improvement in 6MWD
and HRQL scores was found to be highly significant in the intervention group in comparison to the control group (P<0.05). The HRQL scores and 6MWD also increased after 12 weeks in the control group but failed to attain statistical significance. The differences observed in serum protein, MUAC and SFT between the groups after 12 weeks were not significant (Tables 3 and 4) . Slight improvements were observed in the lung function parameters (FEV1, FVC, and FEV1/FVC) in both groups at the end of 12 weeks, although these changes were not statistically significant (Table 3) . Also, independent t-test used to compare differences in lung function parameters post-supplementation vs pre-supplementation did not show a significant change between the groups at the end of the study period (Table 4 ).
The treatment was well tolerated and no adverse events were recorded. None of the patients had an acute exacerbation requiring emergency room treatment or hospitalization. There was no impact on lipid profile, liver function tests, renal function or blood pressure. The intervention group tolerated the high-protein, high-calorie diet without any complication. At the end of the study period, a significant difference between the study and control groups was observed in the 6MWT and HRQL (P< 0.05, Table 4 ). These parameters were also found to be positively correlated in response to nutritional supplementation at the end of the study (Table 5 and Figure 1 ). This may be due to the fact that the duration of supplementation was not long enough and dietary intake was not increased adequately in such patients.
Pulmonary function parameters did not improve significantly after nutritional intervention in our study. Also, the duration of supplementation was only 12 weeks in our study; whereas, studies which showed significant improvement were done for much longer period ( Therefore, we confirm that cost-effectiveness of this intervention was efficient and that nutritional support in this study could be applied in clinical practice in India where incidence of malnutrition in COPD is quite high and most of the patients come from low socioeconomic background.
Our study had few limitations. Firstly, the sample size was small. A small difference between groups would not be detected as significant with small samples. A study with larger sample size and of longer duration of time to look into the benefits of nutritional intervention in underweight COPD patients is warranted.
Secondly, the nutritional intake was not standardized.
Varying intake of dietary antioxidants also might have affected the results. It was not feasible to keep all the patients on a standardized diet in our study as all the patients were recruited from outpatient clinics. Another limitation was the potential bias arising from noninclusion of female patients in the study. While we would have liked to include both male and female patients in comparable ratio, the number of male patients with COPD reporting to the outpatient clinic of the hospital far exceeded the number of female patients. This is possibly related to the fact that smoking in female subjects is much less common in India (40) and therefore, smoking-related COPD is much less prevalent. 
